Evidence suggests that the combination of viral vector vaccines and mRNA vaccines produces good levels of antibodies against the COVID-19 causing coronavirus, the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) said in a joint statement.